COLORADO CAN LLC has a total of 15 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, chemical engineering and organic fine chemistry are ENTREGA INC, SHANXI PUDE PHARMACEUTICAL CO LTD and SHANGHAI WD PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Israel | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Organic fine chemistry | |
#4 | Medical technology | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds | |
#4 | Syringes | |
#5 | Chemical or physical processes | |
#6 | Mixing | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rebits Lia | 8 |
#2 | Sievers Robert E | 7 |
#3 | Sievers Robert | 5 |
#4 | Gildelamadrid Xuno | 3 |
Publication | Filing date | Title |
---|---|---|
AU2018208673A1 | Dry powder formation using a variably constrained, divided pathway for mixing fluid streams | |
AU2016215094A1 | Purified CBD and CBDA, and methods, compositions and products employing CBD or CBDA |